Answers are grounded in this paper and cite their sources.
Structural study uncovers 1.95 Å diffraction for a de novo protein with left-handed beta-alpha-beta units, indicating experimental phasing is required beyond computational models.
A newly designed protein featuring a rare left-handed βαβ motif has successfully been crystallized and characterized by preliminary X-ray diffraction. The computational design was conducted using a combination of Rosetta BluePrintBDR , ProteinMPNN and AlphaFold 2, generating eight candidates based on predicted stability and folding accuracy. The final construct was expressed, purified and crystallized in space group P 2 1 . Complete X-ray diffraction data were collected on the BL2S1 beamline at the Aichi Synchrotron and processed to 1.95 Å resolution. Despite multiple attempts, molecular replacement using the AlphaFold 2 model did not yield a conclusive solution, suggesting that alternative phasing methods or refined modeling approaches will be needed. This work highlights both the promise and the challenges of pushing protein biodesign into underexplored structural motifs and provides a foundation for future structural and functional investigations.
No takes yet. Share an insight, caveat, or question.
Tomita et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: